KLC1
Basic information
Region (hg38): 14:103561896-103714249
Previous symbols: [ "KNS2" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the KLC1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 23 | 23 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 31 | 45 | ||||
Total | 0 | 0 | 54 | 6 | 9 |
Variants in KLC1
This is a list of pathogenic ClinVar variants found in the KLC1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-103561922-G-C | Inborn genetic diseases | Uncertain significance (Dec 15, 2023) | ||
14-103561923-G-A | Inborn genetic diseases | Uncertain significance (May 25, 2022) | ||
14-103561946-G-A | Inborn genetic diseases | Uncertain significance (Oct 12, 2022) | ||
14-103562004-G-A | Inborn genetic diseases | Uncertain significance (Dec 21, 2023) | ||
14-103562786-C-A | Benign (Jun 14, 2018) | |||
14-103562805-G-A | Likely benign (Jul 07, 2018) | |||
14-103562851-C-CCCG | Benign (Jul 10, 2018) | |||
14-103562909-G-A | Benign (Jun 23, 2018) | |||
14-103562952-G-T | not specified | Benign (Nov 14, 2016) | ||
14-103562968-G-A | COA8-related disorder | Likely benign (Sep 06, 2022) | ||
14-103562970-C-G | Inborn genetic diseases | Uncertain significance (May 30, 2024) | ||
14-103562970-C-T | Inborn genetic diseases | Uncertain significance (Sep 14, 2022) | ||
14-103562974-C-T | Likely benign (Nov 01, 2022) | |||
14-103562976-C-A | Uncertain significance (Apr 17, 2022) | |||
14-103562986-C-T | Likely benign (Aug 23, 2022) | |||
14-103562987-A-AG | Mitochondrial complex IV deficiency, nuclear type 1 • Mitochondrial complex 4 deficiency, nuclear type 17 • Inborn genetic diseases | Conflicting classifications of pathogenicity (Oct 12, 2022) | ||
14-103562991-G-A | Uncertain significance (Jan 15, 2022) | |||
14-103562993-C-T | Inborn genetic diseases | Uncertain significance (Mar 21, 2022) | ||
14-103562995-T-G | Likely benign (Jan 02, 2024) | |||
14-103563002-A-G | Inborn genetic diseases | Uncertain significance (Jan 08, 2024) | ||
14-103563003-T-C | Inborn genetic diseases | Uncertain significance (Sep 26, 2023) | ||
14-103563003-T-G | Inborn genetic diseases | Uncertain significance (Dec 07, 2023) | ||
14-103563009-T-C | not specified | Benign (Jan 26, 2024) | ||
14-103563014-C-A | COA8-related disorder | Likely benign (May 20, 2019) | ||
14-103563021-G-A | Uncertain significance (Jul 12, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
KLC1 | protein_coding | protein_coding | ENST00000452929 | 14 | 139656 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.371 | 0.629 | 125731 | 0 | 17 | 125748 | 0.0000676 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.22 | 189 | 361 | 0.523 | 0.0000216 | 4083 |
Missense in Polyphen | 40 | 129.36 | 0.30922 | 1345 | ||
Synonymous | -0.0887 | 144 | 143 | 1.01 | 0.00000949 | 1119 |
Loss of Function | 4.27 | 8 | 35.4 | 0.226 | 0.00000178 | 435 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000619 | 0.0000544 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000891 | 0.0000879 |
Middle Eastern | 0.0000619 | 0.0000544 |
South Asian | 0.000133 | 0.000131 |
Other | 0.000171 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Kinesin is a microtubule-associated force-producing protein that may play a role in organelle transport. The light chain may function in coupling of cargo to the heavy chain or in the modulation of its ATPase activity.;
- Pathway
- Salmonella infection - Homo sapiens (human);Signal Transduction;Vesicle-mediated transport;Membrane Trafficking;RHO GTPases activate KTN1;Kinesins;Factors involved in megakaryocyte development and platelet production;RHO GTPase Effectors;Signaling by Rho GTPases;Hemostasis;COPI-dependent Golgi-to-ER retrograde traffic;Golgi-to-ER retrograde transport;Arf6 trafficking events;Intra-Golgi and retrograde Golgi-to-ER traffic
(Consensus)
Recessive Scores
- pRec
- 0.154
Intolerance Scores
- loftool
- 0.690
- rvis_EVS
- -0.49
- rvis_percentile_EVS
- 22.36
Haploinsufficiency Scores
- pHI
- 0.221
- hipred
- N
- hipred_score
- 0.466
- ghis
- 0.590
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.539
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Klc1
- Phenotype
- cellular phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- intracellular protein transport;retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;microtubule-based movement;viral process;antigen processing and presentation of exogenous peptide antigen via MHC class II;protein localization to synapse;stress granule disassembly
- Cellular component
- cytosol;kinesin complex;microtubule;membrane;growth cone;cytoplasmic vesicle;neuronal cell body
- Molecular function
- motor activity;microtubule motor activity;protein binding;tubulin binding